Concepedia

Keiji Yoshioka

KY

5

Publications

112

Citations

5

H-Index

2014

Active since

Affiliations

Seikagaku Corporation (Japan)(Current)

Keiji Yoshioka is an author at Seikagaku Corporation (Japan) specializing in engineering, tissue engineering, and osteoarthritis.

ORCID

Top concepts

Publications per year

2014–2019

5

Publications

5

Biocompatibility of cross-linked hyaluronate (Gel-200) for the treatment of knee osteoarthritis

Masakazu Ishikawa, Keiji Yoshioka, Koutarou URANO et al. · Osteoarthritis and Cartilage · 2014 · 27 citations · Full text

, , +12

Pharmacological effects of N-[2-[[2-[2-[(2,6-dichlorophenyl)amino]phenyl]acetyl]oxy]ethyl]hyaluronamide (diclofenac Etalhyaluronate, SI-613), a novel sodium hyaluronate derivative chemically linked with diclofenac

Keiji Yoshioka, Tomochika Kisukeda, Ryoji Zuinen et al. · BMC Musculoskeletal Disorders · 2018 · 25 citations · Full text

Effect of diclofenac etalhyaluronate (SI-613) on the production of high molecular weight sodium hyaluronate in human synoviocytes

Tomochika Kisukeda, Junichi Onaya, Keiji Yoshioka · BMC Musculoskeletal Disorders · 2019 · 25 citations · Full text

Pharmacological effects of novel cross-linked hyaluronate, Gel-200, in experimental animal models of osteoarthritis and human cell lines

Keiji Yoshioka, Yosuke Yasuda, Tomochika Kisukeda et al. · Osteoarthritis and Cartilage · 2014 · 20 citations · Full text

, , +11

Biocompatibility study of different hyaluronan products for intra-articular treatment of knee osteoarthritis

Keiji Yoshioka, Madoka Katayama, Takeo Nishiyama et al. · BMC Musculoskeletal Disorders · 2019 · 15 citations · Full text

Rows per page

1–5 of 5